Dongsung Pharm Co Ltd (002210):企業の財務・戦略的SWOT分析

◆英語タイトル:Dongsung Pharm Co Ltd (002210) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2908
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Dongsung Pharm Co Ltd (002210) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dongsung Pharm Co Ltd (Dongsung) focuses on the development, manufacturing and commercialization of pharmaceutical products in multiple therapeutic areas. The company’s product portfolio comprises anti-rheumatic and anti-inflammatory analgesics, gastrointestinal drugs, anti-inflammatory enzymes, antispasmodic agents, respiratory agents, anti-histamine, dermatologicals, antidiarheals, antibiotics, antifungals, oral hypoglycemic agents, hypotonics and sedatives, hormones indicated for the treatment respiratory system diseases, digestive system, motion sickness, cardiovascular system, vitamins, nutritional supplements, and other products. It also manufactures cosmetics including moisturizers, wrinkle care and whitening products, men care products, and hair dyes and multivitamins. Dongsung provides its products in domestic and overseas market. Dongsung is headquartered in Seoul, South Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Dongsung Pharm Co Ltd – Key Facts 5
Dongsung Pharm Co Ltd – Key Employees 6
Dongsung Pharm Co Ltd – Key Employee Biographies 7
Dongsung Pharm Co Ltd – Major Products and Services 8
Dongsung Pharm Co Ltd – History 10
Dongsung Pharm Co Ltd – Company Statement 11
Dongsung Pharm Co Ltd – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Dongsung Pharm Co Ltd – Business Description 14
Dongsung Pharm Co Ltd – Corporate Strategy 15
Dongsung Pharm Co Ltd – SWOT Analysis 16
SWOT Analysis – Overview 16
Dongsung Pharm Co Ltd – Strengths 16
Dongsung Pharm Co Ltd – Weaknesses 17
Dongsung Pharm Co Ltd – Opportunities 18
Dongsung Pharm Co Ltd – Threats 19
Dongsung Pharm Co Ltd – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Dongsung Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Dongsung Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Dongsung Pharm Co Ltd, Recent Deals Summary 30
Section 5 – Appendix 31
Methodology 31
Ratio Definitions 31
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Dongsung Pharm Co Ltd, Key Facts 5
Dongsung Pharm Co Ltd, Key Employees 6
Dongsung Pharm Co Ltd, Key Employee Biographies 7
Dongsung Pharm Co Ltd, Major Products and Services 8
Dongsung Pharm Co Ltd, History 10
Dongsung Pharm Co Ltd, Subsidiaries 12
Dongsung Pharm Co Ltd, Key Competitors 20
Dongsung Pharm Co Ltd, Ratios based on current share price 21
Dongsung Pharm Co Ltd, Annual Ratios 22
Dongsung Pharm Co Ltd, Annual Ratios (Cont...1) 23
Dongsung Pharm Co Ltd, Annual Ratios (Cont...2) 24
Dongsung Pharm Co Ltd, Interim Ratios 26
Dongsung Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Dongsung Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Dongsung Pharm Co Ltd, Recent Deals Summary 30
Currency Codes 31
Capital Market Ratios 31
Equity Ratios 32
Profitability Ratios 32
Cost Ratios 33
Liquidity Ratios 33
Leverage Ratios 34
Efficiency Ratios 34

List of Figures
Dongsung Pharm Co Ltd, Performance Chart (2013 - 2017) 25
Dongsung Pharm Co Ltd, Ratio Charts 27
Dongsung Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Dongsung Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

★海外企業調査レポート[Dongsung Pharm Co Ltd (002210):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Morphotek Inc-製薬・医療分野:企業M&A・提携分析
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Co Ltd is a clinical-stage biotech company that develops novel classes of biological based products. The company offers a pipeline of monoclonal antibodies, antibody drug conjugates, and bispecific antibodies for the treatment of cancer, infla …
  • FAR Ltd (FAR):石油・ガス:M&Aディール及び事業提携情報
    Summary FAR Ltd (FAR), formerly First Australian Resources NL, is an independent oil and gas company that offers acquisition, exploration, production and development of oil and natural gas properties. The company has oilfield appraisal wells and exploration assets in West and East Africa. It operate …
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Rosneft Oil Co (ROSN):石油・ガス:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • Leukocare AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • Vertex Pharmaceuticals Inc (VRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of transformative drugs for the treatment of serious and life-threatening diseases. The company product portfolio includes Orkambi (ivacaftor/lumacaftor) and Kalyd …
  • Boule Diagnostics AB (BOUL):企業の財務・戦略的SWOT分析
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務分析
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Center for Applied Medical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary Center for Applied Medical Research (CIMA), a subsidiary of University of Navarra, is a medical research center that carries out research in the therapeutic areas of cardiovascular sciences, gene therapy and hepatology, oncology and neurosciences. The center also offers support services such …
  • Intel Corporation:企業のM&A・事業提携・投資動向
    Intel Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intel Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Gilead Sciences, Inc.:企業のM&A・事業提携・投資動向
    Gilead Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gilead Sciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Wellmont Health System:企業の戦略的SWOT分析
    Wellmont Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Welltec AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Welltec AS (Welltec) is an oil and gas service provider that develops and offers well technologies and solutions for the oil and gas industries. The company's solutions include wireline services, milling solutions, robotic well solutions, conveyance solutions, clean-out solutions, and mechan …
  • Sebia SA:製品パイプライン分析
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers for diagnosis of cancer. The company's electrophoresis program offer automated system for capillary electrophoresis, gel electrophoresis and electrophoresi …
  • JAND, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary JAND, Inc. (JIN), doing business a warby parker, is a manufacturing company. The company engages in operations of optical manufacturer. JIN product portfolio consists of eyeglasses, sunglasses, and gift cards. The company also manufactures and sale of eyewear for men and women. It also offer …
  • Newfield Exploration Company:戦略・SWOT・企業財務分析
    Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report Summary Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Tanzania Electric Supply Co Ltd:発電所・企業SWOT分析
    Tanzania Electric Supply Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆